v3.26.1
SEGMENT AND GEOGRAPHIC AREA INFORMATION - Information regarding operations by segment (Details)
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 26, 2025
segment
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
item
Mar. 31, 2025
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
SEGMENT INFORMATION              
Number of reportable segments 3     3   2  
Depreciation expense           $ 384,165 $ 432,595
Revenues:              
Total revenues   $ 1,024,111 $ 762,822 $ 1,589,505 $ 1,633,113 2,136,935 2,113,490
Gross profit   826,786 395,518 1,142,143 1,001,757 838,907 974,840
Segment information              
Selling, general and administrative   2,591,647 2,923,704 15,940,157 5,492,981 10,868,590 11,049,537
Research and development   372,149 849,358 830,711 1,864,368 6,016,912 3,593,750
Total operating expenses   7,577,369 3,773,062 26,601,007 7,357,349 16,885,502 14,643,287
(Loss) income from segment operations   (6,750,583) (3,377,544) (25,458,864) (6,355,592) (16,046,595) (13,668,447)
Product revenues              
Revenues:              
Total revenues   1,007,903 548,638 1,562,996 1,044,485 1,424,147 1,074,813
Service revenues              
Revenues:              
Total revenues   16,208 214,184 26,509 588,628 712,788 1,038,677
Therapeutic DNA Production              
SEGMENT INFORMATION              
Depreciation expense           344,008 164,275
DNA Tagging and Security Products and Services              
SEGMENT INFORMATION              
Depreciation expense           40,157 266,677
Operating segment              
Revenues:              
Total revenues   1,024,111 983,374 1,589,505 2,179,991 2,136,935 3,431,419
Gross profit   826,786 370,847 1,142,143 1,054,954 838,907 1,016,879
Segment information              
Selling, general and administrative   913,405 1,682,711 11,333,971 3,446,753 5,476,182 6,438,685
Research and development   383,894 785,729 830,711 1,759,340 5,576,506 3,408,663
Total operating expenses   5,910,872 2,468,440 21,994,821 5,206,093 11,052,688 9,847,350
(Loss) income from segment operations   (5,084,086) (2,097,593) (20,852,678) (4,151,139) (10,213,781) (8,830,469)
Operating segment | Product revenues              
Revenues:              
Total revenues   1,007,903 548,638 1,562,996 1,044,485 1,424,147 1,074,813
Operating segment | Service revenues              
Revenues:              
Total revenues   16,208 214,184 26,509 588,628 712,788 1,038,677
Operating segment | Clinical laboratory service revenues              
Revenues:              
Total revenues     221,272   548,438   1,330,849
Operating segment | Therapeutic DNA Production              
Revenues:              
Total revenues   638,423 467,209 1,090,234 614,650 988,118 895,354
Gross profit   474,858 290,735 783,468 403,233 336,666 678,167
Segment information              
Selling, general and administrative   106,894 1,053,968 624,386 1,856,769 4,203,069 3,065,288
Research and development   364,667 652,473 786,641 1,424,798 5,436,239 2,402,151
Total operating expenses   449,988 1,706,441 1,411,027 3,281,567 9,639,308 5,467,439
(Loss) income from segment operations   24,870 (1,415,706) (627,559) (2,878,334) (9,302,642) (4,789,272)
Operating segment | Therapeutic DNA Production | Product revenues              
Revenues:              
Total revenues   638,423 419,412 1,088,971 507,408 828,806 560,000
Operating segment | Therapeutic DNA Production | Service revenues              
Revenues:              
Total revenues     47,797 1,263 107,242 159,312 335,354
Operating segment | MDx Testing Services              
Revenues:              
Total revenues     295,613   546,878   1,317,929
Gross profit     132,395   1,963   (49,831)
Segment information              
Selling, general and administrative     329,904   551,924   1,127,462
Research and development     60,127   136,766   311,927
Total operating expenses     390,031   688,690   1,439,389
(Loss) income from segment operations     (257,636)   (686,727)   (1,489,220)
Operating segment | MDx Testing Services | Product revenues              
Revenues:              
Total revenues     129,226        
Operating segment | MDx Testing Services | Service revenues              
Revenues:              
Total revenues     166,387        
Operating segment | MDx Testing Services | Clinical laboratory service revenues              
Revenues:              
Total revenues         548,438   1,330,849
Operating segment | DNA Tagging and Security Products and Services              
Revenues:              
Total revenues   385,688 220,552 499,271 1,018,463 1,148,817 1,218,136
Gross profit   351,928 (52,283) 358,675 649,758 502,241 388,543
Segment information              
Selling, general and administrative   71,577 298,839 118,557 1,038,060 1,273,113 2,245,935
Research and development   19,227 73,129 44,070 197,776 140,267 694,585
Total operating expenses   90,804 371,968 162,627 1,235,836 1,413,380 2,940,520
(Loss) income from segment operations   261,124 (424,251) 196,048 (586,078) (911,139) (2,551,977)
Operating segment | DNA Tagging and Security Products and Services | Product revenues              
Revenues:              
Total revenues   369,480   474,025 537,077 595,341 514,813
Operating segment | DNA Tagging and Security Products and Services | Service revenues              
Revenues:              
Total revenues   $ 16,208   $ 25,246 481,386 $ 553,476 703,323
Operating segment | DNA Tagging and Security Products and Services | Clinical laboratory service revenues              
Revenues:              
Total revenues     221,272        
Less intersegment revenues              
Revenues:              
Total revenues     (720)   (1,560)   (12,920)
Less intersegment revenues | MDx Testing Services              
Revenues:              
Total revenues         $ (1,560)   $ (12,920)
Less intersegment revenues | DNA Tagging and Security Products and Services              
Revenues:              
Total revenues     $ (720)